Nicotinamide phosphoribosyltransferase (NAMPT) is a regulator of the intracellular
nicotinamide adenine dinucleotide (NAD) pool. NAD is an essential coenzyme involved in …

NAD+, a co-enzyme involved in a great deal of biochemical reactions, has been found to be
a network node of diverse biological processes. In mammalian cells, NAD+ is synthetized …

Background. Cerebral ischemic stroke (CIS) is a common cerebrovascular disease whose
main risks include necrosis, apoptosis, and cerebral infarction. But few therapeutic advances …

Nicotinamide phosphoribosyltransferase (NAMPT) is an adipokine‐enzyme, which was
described as to play bioactivities both in the intracellular and in the extracellular …

Nicotinamide phosphoribosyltransferase (NAMPT), also an adipokine known as visfatin, acts
via enzymatic activity to synthesize nicotinamide mononucleotide (NMN) and then to …

Obesity predisposes the affected individuals to several metabolic, inflammatory,
cardiovascular and malignant pathologies and is a top risk factor for premature mortality. It is …

Nicotinamide phosphoribosyltransferase (NAMPT) is a key rate-limiting enzyme in the
nicotinamide adenine dinucleotide (NAD+) salvage pathway, primarily catalyzing the …

Nicotinamide adenine dinucleotide (NAD+) is the most important hydrogen carrier in cell
redox reactions. It is involved in mitochondrial function and metabolism, circadian rhythm …

Astragalus and Panax notoginseng are commonly used to treat cardio-cerebrovascular
diseases in China and are often combined together to promote curative effect. We speculate …

Aim Visfatin, a novel adipokine, is predominantly produced by visceral adipose tissue and
exists in intracellular and extracellular compartments. The intracellular form of visfatin is …